Biomm SA (BIOM3):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biomm SA (BIOM3) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8084
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses its technology to companies interested in producing insulin. Biomm’s technology is used for the production of therapeutic proteins such as calcitonin, interferons and growth hormones. The company serves pharmaceutical, biofuels and food industries. It collaborates with research foundation, universities and institutes. The company markets its products to the US, the UK, Russia, Germany, Canada, Brazil and other countries. Biomm is headquartered in Belo Horizonte, Brazil.

Biomm SA (BIOM3) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biomm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biomm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biomm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biomm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biomm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biomm SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MannKind and Biomm Enter into Distribution Agreement 10
Bioton Enters into Distribution Agreement with Biomm 11
Equity Offering 12
Biomm Receives Approval For Private Placement Of Shares For Up To US$99 Million 12
Biomm SA – Key Competitors 13
Biomm SA – Key Employees 14
Biomm SA – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Biomm SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Biomm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biomm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biomm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biomm SA, Deals By Therapy Area, 2012 to YTD 2018 8
Biomm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MannKind and Biomm Enter into Distribution Agreement 10
Bioton Enters into Distribution Agreement with Biomm 11
Biomm Receives Approval For Private Placement Of Shares For Up To US$99 Million 12
Biomm SA, Key Competitors 13
Biomm SA, Key Employees 14

List of Figures
Biomm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biomm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biomm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biomm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biomm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biomm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biomm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biomm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Biomm SA (BIOM3):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bicycle Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bicycle Therapeutics Ltd (Bicycle Therapeutics) is a biotechnology company that develops bicyclic peptides Medicines for the treatment of cancers and other debilitating diseases. The company's proprietary bicyclic peptide technology enables systematic cyclisation of peptides and helps to ide …
  • Visonic Ltd.:企業の戦略的SWOT分析
    Visonic Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • China Unicom (Hong Kong) Limited:企業の戦略・SWOT・財務情報
    China Unicom (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report Summary China Unicom (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • ProThera Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ProThera Biologics Inc (ProThera), formerly ProThera Biologics LLC is a biotherapeutics company that develops novel products based on Inter-alpha Inhibitor Proteins. The company offers development of commercial potential of IAIP for treating acute, life-threatening inflammatory diseases. Pro …
  • PT Central Proteina Prima Tbk (CPRO)
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Dentsu Inc. (4324):企業の財務・戦略的SWOT分析
    Dentsu Inc. (4324) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BB&T Corporation:企業の戦略・SWOT・財務情報
    BB&T Corporation - Strategy, SWOT and Corporate Finance Report Summary BB&T Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Calliditas Therapeutics AB-製薬・医療分野:企業M&A・提携分析
    Summary Calliditas Therapeutics AB (Calliditas), formerly, Pharmalink AB is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; a …
  • Sasol Limited:企業の戦略・SWOT・財務分析
    Sasol Limited - Strategy, SWOT and Corporate Finance Report Summary Sasol Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SK Bioland Co Ltd:企業の戦略・SWOT・財務分析
    SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • State Atomic Energy Corporation Rosatom:電力:M&Aディール及び事業提携情報
    Summary State Atomic Energy Corporation Rosatom (ROSATOM) is the Russian Federation national nuclear corporation. It provides a wide range of services in the nuclear production chain, from uranium exploration and mining, uranium conversion and enrichment, nuclear fuel fabrication, mechanical enginee …
  • Kareo Inc:医療機器:M&Aディール及び事業提携情報
    Summary Kareo Inc (Kareo) provides a cloud-based medical technology platform that meets the needs of healthcare providers. The company offers cloud-based electronic health records (EHR) that helps clinicians to manage the care of the patients and record or access required information at the point of …
  • Arabtec Holding:企業の戦略・SWOT・財務情報
    Arabtec Holding - Strategy, SWOT and Corporate Finance Report Summary Arabtec Holding - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Boubyan Petrochemical Co:企業の戦略・SWOT・財務分析
    Boubyan Petrochemical Co - Strategy, SWOT and Corporate Finance Report Summary Boubyan Petrochemical Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nynas AB:企業の戦略的SWOT分析
    Nynas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Enbridge Energy Partners, L.P.:企業の戦略・SWOT・財務情報
    Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Qantas Airways Limited:企業の戦略・SWOT・財務情報
    Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Roper Technologies Inc (ROP):医療機器:M&Aディール及び事業提携情報
    Summary Roper Technologies Inc (Roper), formerly Roper Industries Inc, is a diversified technology company. It designs and develops software, and engineered products and solutions. It offers both software-as-a-service and licensed to customers. The company serves healthcare, water, food, transportat …
  • Vaccinogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaccinogen Inc (Vaccinogen) is an immunotherapy company that develops products for the treatment of solid tumors. The company provides oncovax products. It provides immunotherapy products to treat solid tumors and commercializes autologous tumor vaccine products. Vaccinogen's products are us …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆